R&D Pipeline of J2HBiotech

HOME / R&D / R&D Center, R&D Pipeline, R&D Network
DISCOVERY PRECLINICAL CLINICAL
PHASE1 PHASE2 PHASE3

J2H-1701 (Infectious Disease, anti-HCV)
J2H-1702 (Nonalcoholic Steatohepatitis, NASH)
TEJ-1704 (Amyotrophic Lateral Sclerosis, ALS)
J2H-1801 (Multiple Sclerosis,MS)
J2H-1802 (Psoriasis)
J2H-1803 (Duchenne Muscular Dystrophy)
J2H-1908 (Solid Tumor)
J2H-P1904 (Liver Fibrosis)
J2H-P1905 (Idiopathic Pulmonary Fibrosis, IPF)
J2H-PROTAC (Proteolysis-targeting chimera against Non-small-cell lung carcinoma)